Ftse Mib
32.612,27
-2,97%
DAX
17.993,46
-1,48%
S&P 500
5.419,87
-0,26%
NASDAQ
17.657,86
-0,05%
Bitcoin
66.895,80
0,21%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Synlogic Com USD0.001 (MIRN) Synlogic Com USD0.001 (MIRN) Notizie

MIRN

MIRNA THERAPEUTICS, INC. (MIRN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MIRN
DataOraFonteTitoloSimboloCompagnia
26/09/201722:07Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:MIRNSynlogic Com USD0.001
19/09/201718:06Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201720:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:MIRNSynlogic Com USD0.001
07/09/201720:10Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MIRNSynlogic Com USD0.001
06/09/201712:04Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201722:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MIRNSynlogic Com USD0.001
30/08/201722:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIRNSynlogic Com USD0.001
28/08/201722:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MIRNSynlogic Com USD0.001
25/08/201714:15Business WireMirna Therapeutics Announces Results of Annual Meeting of StockholdersNASDAQ:MIRNSynlogic Com USD0.001
04/08/201712:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MIRNSynlogic Com USD0.001
14/07/201712:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:MIRNSynlogic Com USD0.001
13/07/201722:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:MIRNSynlogic Com USD0.001
11/07/201714:14Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MIRNSynlogic Com USD0.001
21/06/201723:13Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:MIRNSynlogic Com USD0.001
09/06/201722:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MIRNSynlogic Com USD0.001
16/05/201712:30Business WireSynlogic and Mirna Therapeutics Agree to MergerNASDAQ:MIRNSynlogic Com USD0.001
09/05/201723:30Business WireMirna Therapeutics Reports First Quarter 2017 Financial ResultsNASDAQ:MIRNSynlogic Com USD0.001
15/03/201711:12Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MIRNSynlogic Com USD0.001
14/03/201723:11Business WireMirna Therapeutics Reports Financial Results for the Fourth Quarter and Full Year Ended December 31, 2016NASDAQ:MIRNSynlogic Com USD0.001
14/02/201717:42Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MIRNSynlogic Com USD0.001
10/11/201622:59Business WireMirna Therapeutics Reports Third Quarter 2016 Financial Results and MRX34 Clinical Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
20/09/201622:05Business WireMirna Therapeutics Halts Phase 1 Clinical Study of MRX34NASDAQ:MIRNSynlogic Com USD0.001
31/08/201613:00Business WireMirna Therapeutics to Participate in Two Healthcare Investor Conferences in SeptemberNASDAQ:MIRNSynlogic Com USD0.001
15/08/201613:00Business WireMirna Therapeutics Reports Second Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
05/07/201613:00Business WireMirna Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare ConferenceNASDAQ:MIRNSynlogic Com USD0.001
30/06/201613:00Business WireMirna Therapeutics Appoints Perry Nisen, M.D., Ph.D., to Its Board of DirectorsNASDAQ:MIRNSynlogic Com USD0.001
06/06/201618:00Business WireMirna Therapeutics Announces Clinical Data on its Lead microRNA Therapeutic Presented at ASCONASDAQ:MIRNSynlogic Com USD0.001
12/05/201622:05Business WireMirna Therapeutics Reports First Quarter 2016 Financial Results and Program UpdatesNASDAQ:MIRNSynlogic Com USD0.001
27/04/201622:11Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:MIRNSynlogic Com USD0.001
27/04/201622:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MIRNSynlogic Com USD0.001
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MIRN

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
BPE
Bper Banca
BIT
LDO
Leonardo
BIT
BAMI
Banco BPM
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
NEXI
Nexi S.p.A
BIT
TIT
Telecom Italia
BIT
PST
Poste Italiane S.p.a
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network